Fulgent Genetics vs Personalis
FLGT and PSNL side by side, both in health services. Figures are trailing twelve months unless noted, from SEC filings and end-of-day prices.
How FLGT and PSNL compare
Personalis is the larger company, worth 2.4 times as much as Fulgent Genetics ($1.6B against $662M).
Fulgent Genetics grew revenue faster over the last twelve months (6.8% versus −13.3% for Personalis).
Fulgent Genetics keeps more of each dollar of sales as profit, with a net margin of −26.0% compared with −154% at Personalis.
Fulgent Genetics scores higher on the StockData Score (7 against 5 for Personalis), which adds up 30 checks on valuation, growth, past performance, financial health and dividends.
Key numbers
A dot marks the better figure where higher or lower is clearly better.
| Metric | FLGT | PSNL |
|---|---|---|
| Size and price | ||
| Market cap | $662M | $1.6B |
| Share price | $24.07 | $14.80 |
| Change, 1 year | −18.6% | 94.7% |
| Change, 5 years | −75.3% | 5.8% |
| Beta (5Y) | 0.50 | 1.24 |
| Employees | 1,300 | 260 |
| StockData Score | ||
| Total score | 7 (better) | 5 |
| Valuation score | 3 (better) | 0 |
| Growth score | 0 | 0 |
| Performance score | 1 (better) | 0 |
| Health score | 3 | 5 (better) |
| Dividend score | 0 | 0 |
| Valuation | ||
| P/S | 2.0× (better) | 22.7× |
| P/B | 0.7× (better) | 6.7× |
| FCF yield | −15.7% | −6.4% (better) |
| Fair value | $45.46 | $3.33 |
| Margin of safety | 47.0% (better) | −344% |
| Growth | ||
| Revenue growth (TTM) | 6.8% (better) | −13.3% |
| Revenue growth, 5Y average | −5.2% | −2.4% (better) |
| Profitability | ||
| Gross margin | 35.6% (better) | 12.7% |
| Operating margin | −37.7% (better) | −164% |
| Net margin | −26.0% (better) | −154% |
| FCF margin | −32.0% (better) | −145% |
| Return on equity | −8.0% (better) | −50.3% |
| Return on invested capital | −10.9% (better) | −450% |
| Financial health | ||
| Debt / equity | 0.00 (better) | 0.00 |
| Interest coverage | −1019.0× | −536.7× (better) |
| Current ratio | 6.34 (better) | 5.28 |
| Altman Z-score | 5.22 | 8.99 (better) |
| Piotroski F-score | 4 | 4 |
| Dividends and buybacks | ||
| Buyback yield | 9.6% (better) | −8.5% |
| Shareholder yield | 9.6% (better) | −8.5% |
| Ownership | ||
| Held by institutions | 57.0% | 79.6% |
| Held by insiders | 39.5% | 15.0% |
| Insider net buying, 12 months | −$286K (better) | −$6.9M |
| Short interest, % of float | 12.1% | 7.4% |
Go deeper
- FLGT stock overview
- FLGT income statement
- FLGT valuation and score
- PSNL stock overview
- PSNL income statement
- PSNL valuation and score
For information only, not investment advice. Check the source filings before relying on any figure.